Search Results - "Sparenborg, Steven"

Bupropion and Naltrexone in Methamphetamine Use Disorder by Trivedi, Madhukar H, Walker, Robrina, Ling, Walter, dela Cruz, Adriane, Sharma, Gaurav, Carmody, Thomas, Ghitza, Udi E, Wahle, Aimee, Kim, Mora, Shores-Wilson, Kathy, Sparenborg, Steven, Coffin, Phillip, Schmitz, Joy, Wiest, Katharina, Bart, Gavin, Sonne, Susan C, Wakhlu, Sidarth, Rush, A. John, Nunes, Edward V, Shoptaw, Steven

“…In a randomized trial involving participants with methamphetamine use disorder, the response among those who received bupropion and naltrexone was 11…”
Get full text

The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment by Tai, Betty, Ph.D, Straus, Michele M., R.Ph., M.S, Liu, David, M.D, Sparenborg, Steven, Ph.D, Jackson, Ron, M.S.W, McCarty, Dennis, Ph.D

“…Abstract The National Institute on Drug Abuse established the National Drug Abuse Treatment Clinical Trials Network (CTN) in 1999 to improve the quality of…”
Get full text

Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers by Babalonis, Shanna, Haney, Margaret, Malcolm, Robert J, Lofwall, Michelle R, Votaw, Victoria R, Sparenborg, Steven, Walsh, Sharon L

“…Highlights • Cannabidiol (CBD) is currently being explored for numerous disease conditions. • CBD is a Schedule I drug; however, abuse liability assessments…”
Get full text

Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis by Haney, Margaret, Malcolm, Robert J, Babalonis, Shanna, Nuzzo, Paul A, Cooper, Ziva D, Bedi, Gillinder, Gray, Kevin M, McRae-Clark, Aimee, Lofwall, Michelle R, Sparenborg, Steven, Walsh, Sharon L

“…Cannabidiol (CBD), a constituent of cannabis with few psychoactive effects, has been reported in some studies to attenuate certain aspects of…”
Get full text

A randomized placebo-controlled trial of N -acetylcysteine for cannabis use disorder in adults by Gray, Kevin M, Sonne, Susan C, McClure, Erin A, Ghitza, Udi E, Matthews, Abigail G, McRae-Clark, Aimee L, Carroll, Kathleen M, Potter, Jennifer S, Wiest, Katharina, Mooney, Larissa J, Hasson, Albert, Walsh, Sharon L, Lofwall, Michelle R, Babalonis, Shanna, Lindblad, Robert W, Sparenborg, Steven, Wahle, Aimee, King, Jacqueline S, Baker, Nathaniel L, Tomko, Rachel L, Haynes, Louise F, Vandrey, Ryan G, Levin, Frances R

“…Highlights • N -acetylcysteine (NAC) was evaluated for cannabis use disorder (CUD) in adults. • All trial participants concurrently received contingency…”
Get full text

From research to the real world: Buprenorphine in the decade of the Clinical Trials Network by Ling, Walter, M.D, Jacobs, Petra, M.D, Hillhouse, Maureen, Ph.D, Hasson, Albert, M.S.W, Thomas, Christie, M.P.H, Freese, Thomas, Ph.D, Sparenborg, Steven, Ph.D, McCarty, Dennis, Ph.D, Weiss, Roger, M.D, Saxon, Andrew, M.D, Cohen, Allan, M.A., M.F.T, Straus, Michele, R.Ph., M.S, Brigham, Gregory, Ph.D, Liu, David, M.D, McLaughlin, Paul, M.A, Tai, Betty, Ph.D

“…Abstract The National Institute on Drug Abuse (NIDA) established the National Drug Abuse Treatment Clinical Trials Network (CTN) in 1999 to bring researchers…”
Get full text

Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and Acceptability by Walker, Robrina, Hillhouse, Maureen, Perrochet, Brian, Sparenborg, Steven, Mooney, Larissa, Ling, Walter

“…OBJECTIVES:This article describes how smartphones were used to monitor and encourage medication adherence in a pilot study evaluating the potential efficacy of…”
Get full text

A multi-site, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence by Winhusen, Theresa, Lewis, Daniel, Sharma, Gaurav, Sparenborg, Steven

Get full text

Safety of combination buprenorphine/naloxone and extended release naltrexone by Lindblad, R, Saxon, A, VanVeldhuisen, Paul, Lu, L, Hu, L, Hasson, A, Thomas, C, Sparenborg, Steven, Mooney, Larissa, Ling, W

Get full text

Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder by Griffin, Margaret L., Dodd, Dorian R., Potter, Jennifer S., Rice, Lindsay S., Dickinson, William, Sparenborg, Steven, Weiss, Roger D.

“…Abstract Background: Given the growing prevalence of prescription opioid dependence and the considerable rates of additional psychopathology in drug…”
Get full text

Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder by Mooney, Larissa J, Hillhouse, Maureen P, Thomas, Christie, Ang, Alfonso, Sharma, Gaurav, Terry, Garth, Chang, Linda, Walker, Robrina, Trivedi, Madhukar, Croteau, David, Sparenborg, Steven, Ling, Walter

“…OBJECTIVES:This 2-stage open-label pilot study evaluated the safety and potential efficacy of naltrexone + bupropion as a pharmacotherapy for methamphetamine…”
Get full text

Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: An efficacy trial conducted in the real world by Winhusen, Theresa, Brady, Kathleen T, Stitzer, Maxine, Woody, George, Lindblad, Robert, Kropp, Frankie, Brigham, Gregory, Liu, David, Sparenborg, Steven, Sharma, Gaurav, VanVeldhuisen, Paul, Adinoff, Bryon, Somoza, Eugene

“…Abstract Cocaine dependence is a significant public health problem for which there are currently no FDA-approved medications. Hence, identifying candidate…”
Get full text

Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems by Ghitza, Udi E, Sparenborg, Steven, Tai, Betty

“…A great divide currently exists between mainstream health care and specialty substance use disorders (SUD) treatment, concerning the coordination of care and…”
Get full text

Mortality in Neonatal Rats Is Increased by Moderate Prenatal Exposure to Some Monoamine Reuptake Inhibitors: A Brief Reviewb by SPARENBORG, STEVEN

Get full text

Mortality in Neonatal Rats Is Increased by Moderate Prenatal Exposure to Some Monoamine Reuptake Inhibitors: A Brief Review b by Sparenborg, Steven

Get full text

Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings by Tai, Betty, Sparenborg, Steven, Ghitza, Udi E, Liu, David

“…The Patient Protection and Affordable Care Act (2010) and the Mental Health Parity and Addiction Equity Act (2008) expand substance use disorder (SUD) care…”
Get full text

Patient registries for substance use disorders by Tai, Betty, Hu, Lian, Ghitza, Udi E, Sparenborg, Steven, VanVeldhuisen, Paul, Lindblad, Robert

“…This commentary discusses the need for developing patient registries of substance use disorders (SUD) in general medical settings. A patient registry is a tool…”
Get full text

The National Drug Abuse Treatment Clinical Trials Network: forging a partnership between research knowledge and community practice by Tai, Betty, Sparenborg, Steven, Liu, David, Straus, Michele

“…The National Drug Abuse Treatment Clinical Trials Network (CTN) has faced many challenges over its first eleven years. This review explores some of these…”
Get full text

Mortality in Neonatal Rats Is Increased by Moderate Prenatal Exposure to Some Monoamine Reuptake Inhibitors: A Brief Review by SPARENBORG, STEVEN

Get full text

Privacy protection for patients with substance use problems by Hu, Lianne Lian, Sparenborg, Steven, Tai, Betty

“…Many Americans with substance use problems will have opportunities to receive coordinated health care through the integration of primary care and specialty…”
Get full text